NovaBridge Biosciences NBP
NASDAQ NBP
$1.36 +0.02 (+1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Cash from Discontinued Operations (2019 - 2025)

Updated

NovaBridge Biosciences (NBP) posted Cash from Discontinued Operations of $7.84 million for Q3 2025, down 70.4% from $26.46 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Cash from Discontinued Operations (2019 - 2025) Analysis & Trends

For FY2024, NovaBridge Biosciences' Cash from Discontinued Operations came in at -$27.5 million.

  • In prior years, NovaBridge Biosciences' Cash from Discontinued Operations was -$109.79 million in FY2023, -$116.66 million in FY2022 and -$150.86 million in FY2021.
  • The Q3 2025 figure stands as the lowest quarterly Cash from Discontinued Operations since Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 7.84 Mn
Sep 30, 2024 26.46 Mn
Sep 30, 2020 -33.64 Mn
Dec 31, 2019 -30.64 Mn
API Access

NovaBridge Biosciences Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=NBP&period=max&api_key=YOUR_API_KEY